Association of prediabetes with ckd progression and adverse cardiovascular outcomes: An analysis of the cric study

25Citations
Citations of this article
47Readers
Mendeley users who have this article in their library.

Abstract

Purpose: Despite our understanding of diabetes as an established risk factor for progressive kidney disease and cardiac complications, the prognostic significance of prediabetes in patients with chronic kidney disease (CKD) remains largely unknown. Methods: Participants of the Chronic Renal Insufficiency Cohort (CRIC) were categorized as having normoglycemia, prediabetes, or diabetes according to fasting plasma glucose, glycated hemoglobin A1c (HbA1c), and treatment with antidiabetic drugs at baseline. Unadjusted and adjusted proportional hazards models were fit to estimate the association of prediabetes and diabetes (versus normoglycemia) with: (1) composite renal outcome (end-stage renal disease, 50% decline in estimated glomerular filtration rate to ≤ 15 mL/min/1.73 m2, or doubling of urine protein-to-creatinine ratio to ≥ 0.22 g/g creatinine); (2) composite cardiovascular (CV) outcome (congestive heart failure, myocardial infarction or stroke); and (3) all-cause mortality. Results: Of the 3701 individuals analyzed, 945 were normoglycemic, 847 had prediabetes and 1909 had diabetes. The median follow-up was 7.5 years. Prediabetes was not associated with the composite renal outcome (adjusted hazard ratio [aHR] 1.13; 95% confidence interval [CI], 0.96–1.32; P = 0.14), but was associated with proteinuria progression (aHR 1.23; 95% CI, 1.03–1.47; P = 0.02). Prediabetes was associated with a higher risk of the composite CV outcome (aHR 1.38; 95% CI, 1.05–1.82; P = 0.02) and a trend towards all-cause mortality (aHR 1.28; 95% CI, 0.99–1.66; P = 0.07). Participants with diabetes had an increased risk of the composite renal outcome, the composite CV outcome, and all-cause mortality. Conclusions: In individuals with CKD, prediabetes was not associated with composite renal outcome, but was associated with an increased risk of proteinuria progression and adverse CV outcomes.

References Powered by Scopus

Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes

9369Citations
N/AReaders
Get full text

Dapagliflozin in patients with heart failure and reduced ejection fraction

4888Citations
N/AReaders
Get full text

Dapagliflozin and cardiovascular outcomes in type 2 diabetes

4622Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Association of the metabolic syndrome with mortality and major adverse cardiac events: A large chronic kidney disease cohort

44Citations
N/AReaders
Get full text

The global burden of disease attributable to high fasting plasma glucose in 204 countries and territories, 1990–2019: An updated analysis for the Global Burden of Disease Study 2019

43Citations
N/AReaders
Get full text

Chronic microvascular complications in prediabetic states—an overview

22Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Neves, J. S., Correa, S., Baptista, R. B., Vieira, M. B., Waikar, S. S., & Mc Causland, F. R. (2020). Association of prediabetes with ckd progression and adverse cardiovascular outcomes: An analysis of the cric study. Journal of Clinical Endocrinology and Metabolism, 105(4), E1772–E1780. https://doi.org/10.1210/clinem/dgaa017

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 8

50%

Researcher 5

31%

Professor / Associate Prof. 2

13%

Lecturer / Post doc 1

6%

Readers' Discipline

Tooltip

Medicine and Dentistry 15

79%

Pharmacology, Toxicology and Pharmaceut... 2

11%

Chemistry 1

5%

Engineering 1

5%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free